Fresubin 2 kcal DRINK from Fresenius SE & Co. KGaA - compact calories for vulnerable patients

Reviewed: ad hoc news B2B & Pro desk. Edited and checked on 2026-06-27, 17:19. Details in the imprint.

Fresubin 2 kcal DRINK lands on the bedside table as a surprisingly small, colorful bottle that feels dense in the hand and smells faintly of vanilla or cappuccino, not hospital. One pull on the straw and the liquid is smooth, slightly thick, clearly richer than ordinary milk.

What Fresubin 2 kcal DRINK does

Fresubin 2 kcal DRINK is a high-energy, high-protein oral nutritional supplement designed for patients at risk of disease-related malnutrition, including older adults and oncology patients.The official Fresubin product page details its indications. Each 150 ml bottle provides around 300 kcal and 20 g of protein, aiming to support weight maintenance and recovery.

The drink is available in multiple flavors such as vanilla, cappuccino, strawberry and lemon, because as product manager Dr. Martina Weber likes to stress in presentations, patients stop drinking formulas that taste purely clinical. That flavor variety is meant to keep long-term supplementation bearable in everyday care home or home-care routines.

Designed for clinical realities

With its 2 kcal per ml density, Fresubin 2 kcal DRINK targets people who cannot manage large volumes but still need energy, for example after surgery or during chemotherapy.Fresenius Kabi describes the product as suitable for volume-restricted patients. Nurses appreciate that one small bottle can be finished in a few quiet minutes, not an entire afternoon.

The formula is usually lactose-free and gluten-free, with a mix of milk protein and vegetable oils plus vitamins and minerals to approximate a balanced meal in liquid form. In practice, clinicians often prescribe two to three bottles per day, which can quickly add 600 to 900 kcal on top of the normal diet.

How it fits into therapy

In German hospitals and care homes, Fresubin 2 kcal DRINK often appears on nutrition care plans alongside parenteral and enteral solutions from Fresenius Kabi.A Fresubin brochure in the UK outlines similar usage patterns. Doctors use it to bridge gaps where normal food intake is insufficient but feeding tubes are not yet necessary.

For the patient, the experience is far more social than a drip. A bottle can be drunk slowly during a quiet TV evening or while chatting with family, which nutrition specialist Prof. Hans Müller cites as a subtle but important psychological advantage in oncology and geriatric wards. That human aspect is part of the reason oral supplements have become standard of care in many guidelines.

Packaging, logistics and everyday annoyances

Each Fresubin 2 kcal DRINK unit comes ready-to-use with a straw and peel-off foil, cutting down preparation time for caregivers. The bottles are stackable, with clear color coding per flavor, making it easier for ward staff to see at a glance what still needs to be given.

What nurses complain about, though, is the sticky residue when patients leave half a bottle for later and forget it. Rinsing cups and checking expiry dates becomes part of the daily routine, especially because the product must be stored cool and consumed within a defined time once opened. In high-volume wards, that adds small but real workload.

Regulation and reimbursement

Fresubin 2 kcal DRINK is classified as a food for special medical purposes, which means it sits in a regulated niche between normal food and drugs. In Germany and many EU countries, it is usually reimbursed when prescribed for documented malnutrition or high risk, which supports stable volumes for Fresenius Kabi.

For Fresenius, that regulatory status is a double-edged sword. It enables payor funding but demands strict safety and labeling compliance, plus ongoing clinical evidence to justify indications. The group therefore invests continuously in studies on nutritional support in oncology and geriatrics to underpin the brand.

Where investors should place it

Net-net, Fresubin 2 kcal DRINK is not a gadget in a supermarket aisle but a quiet workhorse inside a larger clinical nutrition franchise. For Fresenius, these patient-level bottles aggregate into recurring sales streams in hospitals and home care that help smooth out more volatile businesses like project-based hospital services.

Fresenius SE & Co. KGaA shares (ISIN DE0005785604) trade on Xetra, with financial portals such as Finanzen100 recently quoting the Fresenius share price in the high-30-euro range based on late-June 2026 data.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.